Award
Delivery Order #SPE2DR26FHDE3
Delivery Order Awarded to DMS Pharmaceutical for FERAHEME Vials
Buyer
Defense Logistics Agency
Award Amount
$6,084.40
Ceiling
$6,084.40
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26FHDE3
NAICS
424210
This award represents a delivery order contract granted to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract involves the procurement of FERAHEME 510 MG/17 ML vials, a medical pharmaceutical product. This delivery order is part of a larger ongoing Indefinite Delivery Vehicle (IDV) contract previously awarded to DMS Pharmaceutical Group, which secures long-term pharmaceutical supplies for the agency. The significance of this award lies in its role in maintaining the continuous availability of essential medical treatments within government health programs. The scope covers the supply and delivery of specific pharmaceutical vials intended for medical use, ensuring timely access to necessary medications. The contract was awarded under the existing IDV framework, with the delivery order marking a specific procurement event. The delivery is scheduled over a short timeframe, spanning just two days, reflecting prompt fulfillment requirements. Key subcontractor details and competitive bid information are not disclosed, but this award builds on DMS Pharmaceutical's proven performance under the parent IDV contract, highlighting a trusted supplier relationship.
Description
4571280443!FERAHEME 510 MG/17 ML VIAL 17ML